Cinquina, Valeria
 Distribuzione geografica
Continente #
NA - Nord America 1.077
EU - Europa 960
AS - Asia 311
SA - Sud America 7
OC - Oceania 3
AF - Africa 1
Totale 2.359
Nazione #
US - Stati Uniti d'America 1.070
PL - Polonia 600
CN - Cina 108
IT - Italia 91
UA - Ucraina 88
SG - Singapore 68
DE - Germania 48
HK - Hong Kong 44
VN - Vietnam 42
FI - Finlandia 39
GB - Regno Unito 30
FR - Francia 27
TR - Turchia 25
IE - Irlanda 21
ID - Indonesia 15
CA - Canada 7
IN - India 7
BE - Belgio 6
NL - Olanda 5
CL - Cile 4
AU - Australia 3
EC - Ecuador 3
SE - Svezia 3
CZ - Repubblica Ceca 1
LT - Lituania 1
MU - Mauritius 1
PH - Filippine 1
PK - Pakistan 1
Totale 2.359
Città #
Warsaw 600
Fairfield 199
Ashburn 108
Woodbridge 84
Seattle 79
Jacksonville 78
Cambridge 66
Houston 63
Singapore 58
Wilmington 57
Chandler 50
Hong Kong 44
Dong Ket 42
Brescia 38
New York 38
Princeton 38
Helsinki 33
Beijing 29
Istanbul 23
Ann Arbor 22
Dearborn 21
Dublin 21
Jakarta 15
Nanjing 15
Shanghai 13
Des Moines 11
Los Angeles 11
Lancaster 9
San Diego 9
Jinan 8
London 8
Munich 7
Shenyang 7
Hangzhou 5
Limbiate 5
Nanchang 5
Rome 5
Seregno 5
Toronto 5
Brussels 4
Lappeenranta 4
Ottaviano 4
Phoenix 4
Pune 4
Talcahuano 4
Tianjin 4
Chiswick 3
Cuenca 3
Hebei 3
Jiaxing 3
Priolo Gargallo 3
Annapolis 2
Auburn 2
Canberra 2
Changsha 2
Como 2
Florence 2
Fuzhou 2
Haikou 2
Mele 2
Milan 2
Piombino 2
Redwood City 2
Romola 2
San Francisco 2
Santa Clara 2
Sundbyberg 2
The Bronx 2
Waanrode 2
Zhengzhou 2
Acton 1
Amsterdam 1
Boardman 1
Brno 1
Buffalo 1
Camden 1
Cankaya 1
Council Bluffs 1
Crema 1
Denver 1
Frankfurt am Main 1
Greenwich 1
Groningen 1
Guangzhou 1
Gunzenhausen 1
Islamabad 1
Kilburn 1
Lanzhou 1
Markham 1
Melbourne 1
Miami Beach 1
Montreal 1
Palermo 1
Rezzato 1
San Mateo 1
Santa Maria 1
Scottsdale 1
Sioux Falls 1
Taiyuan 1
Taizhou 1
Totale 2.045
Nome #
GLUT10 deficiency leads to oxidative stress and non-canonical αvβ3 integrin-mediated TGFβ signalling associated with extracellular matrix disarray in arterial tortuosity syndrome skin fibroblasts 233
GLUT10 deficiency leads to oxidative stress and non-canonical avb3 integrin-mediated TGF signalling associated with extracellular matrix disarray in arterial tortuosity syndrome skin fibroblasts. 225
Clinical and molecular characterization of an 18-month-old infant with autosomal recessive cutis laxa type 1C due to a novel LTBP4 pathogenic variant, and literature review 187
Expanding the clinical and mutational spectrum of recessive AEBP1-related classical-like Ehlers-Danlos syndrome 167
Genotypic categorization of Loeys-Dietz syndrome based on 24 novel families and literature data 152
Clinical and Molecular Characterization of Classical-Like Ehlers-Danlos Syndrome Due to a Novel TNXB Variant 150
Further defining the phenotypic spectrum of B3GAT3 mutations and literature review on linkeropathy syndromes 132
A novel MAP3K7 splice mutation causes cardiospondylocarpofacial syndrome with features of hereditary connective tissue disorder 110
Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function 109
Expanding the clinical and mutational spectrum of B4GALT7-spondylodysplastic Ehlers-Danlos syndrome 106
Application of the 2017 criteria for vascular Ehlers-Danlos syndrome in 50 patients ascertained according to the Villefranche nosology 99
A classical Ehlers-Danlos syndrome family with incomplete presentation diagnosed by molecular testing 94
Characterization of a Pseudoxanthoma elasticum-like patient with coagulation deficiency, cutaneous calcinosis and GGCX compound heterozygosity 93
Does miR-338, a putative negative regulator of the facilitative glucose transporter 10 (GLUT10), play a role in arterial tortuosity syndrome? 88
Multisystemic manifestations in a cohort of 75 classical Ehlers-Danlos syndrome patients: natural history and nosological perspectives 74
Identification of the novel COL5A1 c.3369_3431dup, p.(Glu1124_Gly1144dup) variant in a patient with incomplete classical Ehlers–Danlos syndrome: The importance of phenotype-guided genetic testing 72
Expanding the PURA syndrome phenotype: A child with the recurrent PURA p.(Phe233del) pathogenic variant showing similarities with cutis laxa 72
Ehlers-Danlos syndrome with lethal cardiac valvular dystrophy in males carrying a novel splice mutation in FLNA 54
Genome-first approach for the characterization of a complex phenotype with combined NBAS and CUL4B deficiency 51
Phacomatosis pigmentovascularis spilorosea and mutation in the PTPN11 gene: new case with significant neurologic impairment 30
Deciphering disease signatures and molecular targets in vascular Ehlers-Danlos syndrome through transcriptome and miRNome sequencing of dermal fibroblasts 21
Phacomatosis pigmentovascularis spilorosea mit Mutation im PTPN11 Gen: neuer Fall mit erheblichen neurologischen Beeinträchtigungen 20
RNA-Seq of Dermal Fibroblasts from Patients with Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders Supports Their Categorization as a Single Entity with Involvement of Extracellular Matrix Degrading and Proinflammatory Pathomechanisms 19
Bridging the Diagnostic Gap for Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders: Evidence of a Common Extracellular Matrix Fragmentation Pattern in Patient Plasma as a Potential Biomarker 17
Truncating variants in the penultimate exon of TGFBR1 escaping nonsense-mediated mRNA decay cause Loeys-Dietz syndrome 16
Looking back and beyond the 2017 diagnostic criteria for hypermobile Ehlers-Danlos syndrome: A retrospective cross-sectional study from an Italian reference center 15
Totale 2.406
Categoria #
all - tutte 11.665
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.665


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020566 0 0 0 0 71 98 72 87 77 71 49 41
2020/2021582 16 44 37 70 51 76 33 60 48 67 23 57
2021/2022145 10 17 8 11 1 6 6 16 5 11 13 41
2022/2023151 22 1 4 5 15 45 5 22 16 3 4 9
2023/2024301 23 7 15 31 22 57 15 15 48 20 11 37
2024/2025148 3 1 15 87 42 0 0 0 0 0 0 0
Totale 2.406